Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
- Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
- Drug Approvals
- Clinical Trial Calendar

Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard

Crypto
Cryptocurrency
Blockchain

Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies

Politics
US
World
White House
Elections
General News

Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard

Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health

Slide Shows

Entertainment
Top Stories
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services

Premium
Intelligent Investor
Biotech Investor NEW
Login

Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us

Business
Corp. News
- Latest Headlines
- Biotech
- Investors
- Stock Alerts
- IPOs
- M&A
Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
Corp. Calendars
Earnings Calendar
FDA Calendars
- Drug Approvals
- Clinical Trial Calendar
Ratings Changes
Economy
- US
- Europe
- Asia
- Global
- Economic Calendar
- Economic Scorecard
Crypto
- Cryptocurrency
- Blockchain
Markets
Market News
Politics
- US
- World
- White House
- Elections
- General News
Forex
Health
Health News
Slide Shows
Entertainment
Entertainment News
- Top Stories
Music News
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre
Content Licensing
Premium
More

Telix Pharmaceuticals Limited (TLX)

Telix, EDAP And Profound Partner To Explore PSMA-PET Imaging In Prostate Cancer Treatment 5/15/2026 7:57:00 AM

Telix Presents Phase 2 OPTIMAL-PSMA Dosimetry Data For TLX597-Tx In Prostate Cancer Treatment 5/1/2026 3:31:03 AM

Telix Pharma Doses First Patient In Phase 3 IPAX BrIGHT Trial Of TLX101-Tx; Prices $600 Mln Bonds 4/15/2026 5:27:13 AM

Regeneron Pharma Partners Telix Pharma To Jointly Develop Radiopharmaceutical Therapies 4/13/2026 6:54:45 AM

Telix Partners With Regeneron To Develop Radiopharmaceutical Therapies 4/13/2026 6:37:28 AM

Telix And Regeneron Partner To Advance Next-Generation Radiopharmaceutical Therapies 4/12/2026 11:28:52 PM

Telix Pharmaceuticals Stock Gains 7% On FDA Acceptance Of Resubmitted NDA For TLX101-Px 4/10/2026 11:03:14 AM

Telix Pharma Shares Climb As FDA Accepts NDA For Brain Cancer Imaging Agent TLX101-Px 4/10/2026 1:04:36 AM

Telix Pharmaceuticals' Resubmitted NDA For Brain Cancer Imaging Agent TLX101-Px1 Accepted By FDA 4/9/2026 9:13:49 PM

Telix Pharmaceuticals Stock Rises 5% Over Strong Revenue Growth In Q1 4/7/2026 11:05:04 AM

Telix Pharma Reports 24% Revenue Growth In Q1; Stock Up 4/7/2026 2:45:16 AM

Telix Pharmaceuticals Q1 Group Revenue Rises; Stock Up 4/6/2026 10:35:31 PM

Weekly Buzz: GSK's Lynavoy Gets FDA Nod; Reproxalap Rejected Again; LNSR Ends Merger Deal 3/20/2026 10:13:56 AM

Telix Resubmits NDA For Brain Cancer Imaging Candidate TLX101-Px To FDA 3/16/2026 5:41:20 AM

Telix Resubmits TLX101-Px NDA To FDA For Brain Cancer Imaging Agent 3/15/2026 8:59:50 PM

Older Articles

Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us | Contact Us | Privacy | Sitemap